Methods of treating chronic inflammatory diseases using a GM-CSF antagonist
The invention is based on the discovery that GM-CSF antagonists can be used for the treatment of chronic inflammatory disease, such as rheumatoid arthritis. Accordingly, the invention provides methods of administering a GM-CSF antagonist, e.g., a GM-CSF antibody, and an anti-folate compounds, e.g.,...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
10.05.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention is based on the discovery that GM-CSF antagonists can be used for the treatment of chronic inflammatory disease, such as rheumatoid arthritis. Accordingly, the invention provides methods of administering a GM-CSF antagonist, e.g., a GM-CSF antibody, and an anti-folate compounds, e.g., methotrexate, to a patient that has RA and pharmaceutical compositions comprising such antagonists. |
---|---|
Bibliography: | Application Number: AU20120202240 |